1. Show article details.

    BRIEF-Select Medical Holdings Sees FY 2020 Earnings Per Share $1.27 To $1.46

    Reuters – 8:07 AM ET 01/27/2020

    Select Medical Holdings Corp (SEM): * SEES FY 2020 EARNINGS PER SHARE $1.27 TO $1.46. * SEES ADJUSTED EBITDA FOR FULL YEAR 2020 TO BE IN RANGE OF $725 MILLION TO $760 MILLION. * SEES FY 2020 CONSOLIDATED NET OPERATING IN RANGE OF $5.575 BILLION TO $5.675 BILLION Source text for Eikon: Further company coverage:

  2. Show article details.

    Select Medical Holdings Corporation Announces Business Outlook for 2020 and Release Date for Fourth Quarter and Full Year 2019 Financial Results

    PR Newswire – 8:00 AM ET 01/27/2020

    MECHANICSBURG, Pa., Jan. 27, 2020 Select Medical Holdings Corporation (SEM), today announced its business outlook for calendar year 2020. Select Medical (SEM) expects consolidated net operating revenues for the full year 2020 to be in the range of $5.575 billion to $5.675 billion.

  3. Show article details.

    BRIEF-MedRisk Acquires SPNet

    Reuters – 2:35 PM ET 01/07/2020

    MedRisk: * MEDRISK ACQUIRES SPNET. * ACQUIRED SELECT PROVIDER NETWORKS, INC. FROM SELECT MEDICAL (SEM), PURCHASE PRICE NOT DISCLOSED Source text for Eikon: Further company coverage:

  4. Show article details.

    MedRisk Acquires SPNet

    Business Wire – 11:01 AM ET 01/07/2020

    MedRisk has acquired Select Provider Networks, Inc. from Select Medical (SEM). Founded in 2008 by Select Medical (SEM), SPNet offers payers a prospective, managed rehabilitation solution to control physical medicine costs that includes a proprietary peer-to-peer utilization management system. Under the new MedRisk ownership, SPNet will retain its name and operate independently.

  5. Show article details.

    Select Medical Corporation Closes Private Placement of $675 Million of 6.250% Senior Notes due 2026

    PR Newswire – 4:15 PM ET 12/10/2019

    MECHANICSBURG, Pa., Dec. 10, 2019 Select Medical Holdings Corporation (SEM), today announced that Select Medical Corporation has completed its private placement of $675 million aggregate principal amount of its 6.250% Senior Notes due 2026 as additional notes under same indenture as Select's existing $550 million aggregate principal amount of 6.250% senior notes due 2026 that were originally issued o...

  6. Select Medical stock price target raised to $25 from $21 at BofA Merrill Lynch

    MarketWatch – 9:42 AM ET 12/06/2019
  7. Show article details.

    BRIEF-Select Medical Announces Pricing And Upsizing Of Its Offering Of Additional $675 Million Of Its 6.25% Senior Notes Due 2026

    Reuters – 5:51 PM ET 12/05/2019

    Select Medical Holdings Corp (SEM): * SELECT MEDICAL CORPORATION ANNOUNCES PRICING AND UPSIZING OF ITS OFFERING OF AN ADDITIONAL $675 MILLION OF ITS 6.250% SENIOR NOTES DUE 2026. * SELECT MEDICAL CORP - OFFERING HAS BEEN UPSIZED FROM PREVIOUSLY ANNOUNCED AMOUNT OF $625 MILLION Source text for Eikon: Further company coverage:

  8. Show article details.

    Select Medical Corporation Announces Pricing and Upsizing of its Offering of an Additional $675 million of its 6.250% Senior Notes due 2026

    PR Newswire – 5:50 PM ET 12/05/2019

    MECHANICSBURG, Pa., Dec. 5, 2019 Select Medical Holdings Corporation (SEM), today announced that Select Medical Corporation has priced its private placement of $675 million aggregate principal amount of its 6.250% senior notes due 2026 as additional notes under the indenture pursuant to which it previously issued $550 million of 6.250% senior notes due 2026.

  9. Show article details.

    BRIEF-Select Medical Corp Proposes Offering Of $625 Mln Aggregate Principal Amount Of 6.250% Senior Notes Due 2026

    Reuters – 9:23 AM ET 12/05/2019

    Select Medical Holdings Corp (SEM): * SELECT MEDICAL CORPORATION ANNOUNCES PROPOSAL TO COMMENCE OFFERING $625 MILLION OF SENIOR NOTES. * Select Medical Holdings Corp (SEM) - SELECT MEDICAL CORPORATION PROPOSES OFFERING OF $625 MILLION AGGREGATE PRINCIPAL AMOUNT OF 6.250% SENIOR NOTES DUE 2026.

  10. Show article details.

    Select Medical Corporation Announces Proposal to Commence Offering $625 Million of Senior Notes

    PR Newswire – 9:18 AM ET 12/05/2019

    MECHANICSBURG, Pa., Dec. 5, 2019 Select Medical Holdings Corporation (SEM), today announced that Select Medical Corporation proposes to commence an offering through a private placement, subject to market and other conditions, of $625 million aggregate principal amount of 6.250% senior notes due 2026.

Page:

Today's and Upcoming Events

  • Feb
    20

    SEM to announce Q4 earnings (Confirmed)

Past Events (last 90 days)

  • Oct
    31

    SEM announced Q3 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.